SIP
PBH icon

Stoneridge Investment Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Stoneridge Investment Partners’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-23,498
Closed -$792K – 164
2018
Q1 		$792K Sell
23,498
-2,357
-9% -$90.4K 0.13% 92
2017
Q4 		$1.15M Buy
25,855
+8,648
+50% +$394K 0.18% 97
2017
Q3 		$862K Sell
17,207
-7,976
-32% -$407K 0.14% 110
2017
Q2 		$1.33M Buy
+25,183
New +$1.35M 0.2% 109

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Stoneridge Investment Partners's PBH Position: Q2 2018 in Review

Stoneridge Investment Partners sold out of Prestige Consumer Healthcare (PBH) in Q2 2018, closing a stake of 23,498 shares — an estimated $792K sold.

Stoneridge Investment Partners first reported a position in PBH in Q2 2017 and held it in 4 quarters. The position peaked at $1.33M in Q2 2017. 237 funds tracked by Wall St. Rank hold PBH as of Q2 2018.

  • Stoneridge Investment Partners reported no remaining Prestige Consumer Healthcare position as of Q2 2018 after selling out during the quarter.
  • Stoneridge Investment Partners sold 23,498 Prestige Consumer Healthcare shares in Q2 2018, an estimated $792K.
  • Stoneridge Investment Partners first reported a position in Prestige Consumer Healthcare in Q2 2017 and held it in 4 quarters.
  • Stoneridge Investment Partners's Prestige Consumer Healthcare position peaked at $1.33M in Q2 2017.
  • 237 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2018.

Based on Stoneridge Investment Partners's 13F filing for Q2 2018, filed 31 Jul 2018.